Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1984 1
1985 1
1992 2
1993 1
1994 2
1995 1
1996 1
1997 2
1998 2
1999 1
2000 1
2001 3
2003 4
2004 5
2005 8
2006 1
2007 6
2008 3
2009 5
2010 7
2011 4
2012 1
2013 2
2014 4
2015 3
2016 6
2017 4
2018 5
2019 3
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G, Ouyang J, McQuade RD, Blais JD, Czerwiec FS, Sergeyeva O; REPRISE Trial Investigators. Torres VE, et al. N Engl J Med. 2017 Nov 16;377(20):1930-1942. doi: 10.1056/NEJMoa1710030. Epub 2017 Nov 4. N Engl J Med. 2017. PMID: 29105594 Free article. Clinical Trial.
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Heerspink HJL, et al. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Lancet. 2019. PMID: 30995972 Clinical Trial.
Current and potential treatment options for hyperphosphatemia.
Carfagna F, Del Vecchio L, Pontoriero G, Locatelli F. Carfagna F, et al. Among authors: pontoriero g. Expert Opin Drug Saf. 2018 Jun;17(6):597-607. doi: 10.1080/14740338.2018.1476487. Epub 2018 May 21. Expert Opin Drug Saf. 2018. PMID: 29783873 Review.
The quality of dialysis water.
Pontoriero G, Pozzoni P, Andrulli S, Locatelli F. Pontoriero G, et al. Nephrol Dial Transplant. 2003 Aug;18 Suppl 7:vii21-5; discussion vii56. doi: 10.1093/ndt/gfg1074. Nephrol Dial Transplant. 2003. PMID: 12953025 Review.
Recent trials on hemodiafiltration.
Locatelli F, Manzoni C, Del Vecchio L, Cavalli A, Pontoriero G. Locatelli F, et al. Among authors: pontoriero g. Contrib Nephrol. 2011;171:92-100. doi: 10.1159/000327202. Epub 2011 May 23. Contrib Nephrol. 2011. PMID: 21625096 Review.
Integrated diet and dialysis programme.
Locatelli F, Andrulli S, Pontoriero G, Di Filippo S, Bigi MC. Locatelli F, et al. Among authors: pontoriero g. Nephrol Dial Transplant. 1998;13 Suppl 6:132-8. doi: 10.1093/ndt/13.suppl_6.132. Nephrol Dial Transplant. 1998. PMID: 9719220 Review. No abstract available.
CKD patients: the dilemma of serum PTH levels.
Pontoriero G, Cozzolino M, Locatelli F, Brancaccio D. Pontoriero G, et al. Nephron Clin Pract. 2010;116(4):c263-8. doi: 10.1159/000318787. Epub 2010 Jul 16. Nephron Clin Pract. 2010. PMID: 20639672 Free article. Review.
84 results